Market Place
Sourcing Support
All News #Library
Biotech
Autobahn Therapeutics at 25th Needham Healthcare Event
08 Apr 2026 //
PHARMIWEB
Autobahn Therapeutics Unveils Elunetirom`s Neuroplasticity
16 Jan 2026 //
PHARMIWEB
Autobahn Therapeutics at 44th Annual JPM Healthcare Conference
17 Dec 2025 //
BUSINESSWIRE
Autobahn Therapeutics To Join 2025 Jefferies London Health Conf
10 Nov 2025 //
BUSINESS WIRE
Autobahn Therapeutics to Participate in Investor Conferences
25 Aug 2025 //
PHARMAWEB
Autobahn Joins Evercore Emerging Biotech Conference
08 Jul 2025 //
BUSINESSWIRE
Autobahn Therapeutics at Jefferies Global Healthcare Conference
27 May 2025 //
BUSINESSWIRE
Autobahn Presents ABX-002 Ph 1 Data at 2025 ASCP
23 May 2025 //
BUSINESSWIRE
Autobahn Therapeutics Starts Ph 2 ABX-002 For Bipolar Depression
08 Jan 2025 //
BUSINESSWIRE
Autobahn Therapeutics to Present at Multiple Investor Conferences
12 Nov 2024 //
BUSINESSWIRE
Autobahn Therapeutics Receives FDA Clearance For ABX-002
22 Oct 2024 //
BUSINESSWIRE
Autobahn Initiates AMPLIFY Phase 2 Trial Of ABX-002
16 Sep 2024 //
BUSINESSWIRE
Autobahn Therapeutics Joins Multiple Upcoming Investor Conferences
10 Sep 2024 //
BUSINESSWIRE
Autobahn Therapeutics Raises 100M In Series C For CNS Drug Pipeline
24 Jul 2024 //
BUSINESSWIRE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.